Desfesoterodine

DB15578InvestigationalSmall molecule

Desfesoterodine is an antimuscarinic agent indicated in the symptomatic treatment of urinary frequency or incontinence. Desfesoterodine is a metabolite of tolterodine.

Chemical structure of Desfesoterodine
Mechanism
Curator reviewed
Formula / weight
C22H31NO2 · 341.487 g/mol (avg)
Also known as
5-Hydroxymethyltolterodine

Resolves to

Compound
UNIIYU871O78GRCAS207679-81-0ChEMBLCHEMBL3348932
Clinical / RWD
ATCG04BD13
Structure
InChIKeyDUXZAXCGJSBGDW-HXUWFJFHSA-NSMILESCC(C)N(CC[C@H](C1=CC=CC=C1)C1=CC(CO)=CC=C1O)C(C)C

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
13ContraindicationsEach with its own population and attribute set
Sign in
6Marketed productsAcross every region we cover
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Desfesoterodine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In